2023
DOI: 10.1016/j.jviromet.2022.114651
|View full text |Cite
|
Sign up to set email alerts
|

Genetic stability of SIV Gag/Tat gene inserted into Del-II in modified vaccinia virus ankara after serial passage of recombinant vector in pCEFs cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…However, depending on the design of the antigen expression cassette, generation may be difficult or even unsuccessful, as we have experienced for an artificial papillomavirus antigen, MfPV3 Ii-E1E2E6E7. Others have reported similar observations ( 23 27 , 42 , 43 ) but only few comparative studies were conducted to analyze this systematically ( 23 , 26 , 27 ). Even in cases when generation of recombinant MVA is successful, their propagation and the generation of bulk material for larger preclinical studies or GMP-grade drug substance or drug product for clinical trials may suffer from transgene instability leading to the emergence of mutated recombinant MVA (mrMVA) with reduced or abrogated antigen expression or modification of the transgene product.…”
Section: Discussionmentioning
confidence: 95%
“…However, depending on the design of the antigen expression cassette, generation may be difficult or even unsuccessful, as we have experienced for an artificial papillomavirus antigen, MfPV3 Ii-E1E2E6E7. Others have reported similar observations ( 23 27 , 42 , 43 ) but only few comparative studies were conducted to analyze this systematically ( 23 , 26 , 27 ). Even in cases when generation of recombinant MVA is successful, their propagation and the generation of bulk material for larger preclinical studies or GMP-grade drug substance or drug product for clinical trials may suffer from transgene instability leading to the emergence of mutated recombinant MVA (mrMVA) with reduced or abrogated antigen expression or modification of the transgene product.…”
Section: Discussionmentioning
confidence: 95%
“…MVA vaccines also employ a costly cell culture, which is one of the main advantages of the plant expression systems described. The issue of transgene stability must be addressed with MVA vaccines, which may affect the development and scaling up of vaccine preparations based on these [ 104 , 105 ].…”
Section: Discussionmentioning
confidence: 99%